Navigation Links
Developer Of Vaccine For Cancer Granted A Prestigious Fellowship

Researcher, Professor Ian Frazer of the University of Queensland (UQ), has been awarded the Smart State Premier's Fellowship. The prestigious Fellowship comes on top// of his recent Australian of the Year award for his work in developing a vaccine for cervical cancer. Under the Smart State Premier's Fellowship, Professor Ian Frazer will get $250,000 a year for the next five years for his UQ Centre for Immunology and Cancer Research at Brisbane’s Princess Alexandra Hospital. Professor Frazer said the money would help further the development of therapeutic vaccines.

The Smart State Premier's Fellowships provide funding to entice experienced and distinguished researchers of national and international prominence to lead research teams in Queensland universities, research institutes, government agencies or industry research facilities.

Prof Frazer said on ABC Radio, that though The Australian of the Year is a great honour but it is very much an honorary title, and now this fellowship will help him to build up his team and get new initiatives going in the way of research, specifically towards the vaccines that they have been striving to get for the last few years.

Deputy Premier, Treasurer and Minister for State Development, Trade and Innovation Anna Bligh announced the funding today who was in Chicago as part of a trade mission. Stating that the Professor Frazer has put Queensland on the map with his ground breaking scientific achievements. She said that the fellowship money would help Prof Frazer translate the success of the cervical cancer vaccine to other cancers and infections.

The professor has been researching the cause of cervical cancer for the past 20 years and has proven the link between cervical cancers and the papilloma virus. He has also developed the world's first vaccine for cervical cancer. This cancer alone kills 270,000 women each year
'"/>




Page: 1

Related medicine news :

1. Male Contraception: Discovery Stirring Interest Among Scientists, Drug Developers
2. Vaccine to quit smoking?
3. First Vaccine Designed for Africa Cleared for Testing in Humans
4. Vaccine for Alzheimer’s diseas
5. Health Officials Recommend Flu Vaccine
6. Smallpox Vaccine May Help Fight Cervical Cancer
7. Panacea Biotech To Market Anthrax Vaccine
8. New Prostate Cancer Vaccine Shows Promise
9. Drug Firm Offers to Donate Smallpox Vaccine
10. Vaccine guards against shingles
11. Vaccine for septic conditions
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/24/2017)... , ... April 24, 2017 , ... Come to PAINWeekEnd ... 4200 Jim Walter Blvd, for an educational and exciting 2-day program. , An ... staff hearing this before they approach patients” about the course entitled Ain't Misbehavin': Decreasing ...
(Date:4/24/2017)... ... April 24, 2017 , ... Donna Parker, L. Ac. reads ... not found any of them to be very practical. She wanted to write a ... make changes in their health. It prompted her in writing “ A Clear Path ...
(Date:4/24/2017)... ... , ... “Reflections of God’s Work”: an enlightening collection of life lessons leading ... of published author, Jerri Broglin, a survivor of great loss who gained insight on ... eye-opener for those searching for answers, as we are finding the answers that are ...
(Date:4/24/2017)... , ... April 24, 2017 , ... “The Saint with ... with Trin, and Omega Station” is the creation of published author, Chris Jackson. ... Metroplex where he works in the Dallas Independent School District teaching English. He is ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... Life of ... University of Florida. The event will be held at 7:30 pm on May 10th ... Block and Drew Copeland of Sister Hazel, will support the UF Collegiate Recovery Community ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017 NeuroVive Pharmaceutical AB ... announced positive preclinical results demonstrating anti-fibrotic effects ... non-alcoholic steatohepatitis (NASH), in an additional well-validated ... NV556 has previously shown similar anti-fibrotic effects ... NeuroVive,s scientists present novel data demonstrating anti-fibrotic ...
(Date:4/19/2017)... Calif. , April 19, 2017  IRIDEX Corporation ... will release financial results for the first quarter 2017 ... 2017.  The Company,s management team will host a corresponding ... p.m. ET. Investors interested in listening to ... 707-0665 for domestic callers or (703) 326-3030 for international ...
(Date:4/19/2017)... April 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... biopharmaceutical company developing new treatments for cancer and ... of its previously announced underwritten public offering of ... public offering price of $2.00 per share, before ... expenses payable by Sorrento.  The net proceeds to ...
Breaking Medicine Technology: